• No results found

Oral Hypoglycemic Agents

IDENTIFICATION, ASSESSMENT AND ANALYSING THE COST EFFECTIVENESS OF ORAL HYPOGLYCEMIC AGENTS FOR PHARMACOECONOMIC EVALUATION IN A TERTIARY CARE TEACHING HOSPITAL

IDENTIFICATION, ASSESSMENT AND ANALYSING THE COST EFFECTIVENESS OF ORAL HYPOGLYCEMIC AGENTS FOR PHARMACOECONOMIC EVALUATION IN A TERTIARY CARE TEACHING HOSPITAL

... with oral hypoglycemic agents were included in the ...all oral hypoglycemic agents, the most cost-effective drug or combination in the hospital was ...prescribed oral ...

14

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents

... of oral hypoglycemic agents (OHAs), with a progressive addition of agents over time before insulin treatment is required to maintain glycemia at ...

13

Impact of oral hypoglycemic agents on mortality among diabetic patients with non muscle invasive bladder cancer: A population based analysis

Impact of oral hypoglycemic agents on mortality among diabetic patients with non muscle invasive bladder cancer: A population based analysis

... several oral hypoglycemic agents could impact disease-specific survival (DSS), but the data are sparse among NMIBC ...other hypoglycemic agent were calculated before and after NMIBC diag- ...

8

SAFETY OF INSULIN ADD ON THERAPY AND ORAL HYPOGLYCEMIC AGENTS (OHGAs) POLYPHARMACY IN TYPE   II DIABETES PATIENTS   A PROSPECTIVE OBSERVATIONAL STUDY

SAFETY OF INSULIN ADD ON THERAPY AND ORAL HYPOGLYCEMIC AGENTS (OHGAs) POLYPHARMACY IN TYPE II DIABETES PATIENTS A PROSPECTIVE OBSERVATIONAL STUDY

... and Oral Hypoglycemic Agents (OHGAs) polypharmacy and to promote safe use of insulin and OHGAs in Type II Diabetes patients, through patient counseling by Clinical pharmacist at Government General ...

14

INCIDENCE OF ADVERSE DRUG REACTIONS AND DRUG INTERACTIONS OF ORAL HYPOGLYCEMIC AGENTS IN TYPE 2 DIABETIC PATIENTS AT GUWAHATHI MEDICAL COLLEGE HOSPITAL

INCIDENCE OF ADVERSE DRUG REACTIONS AND DRUG INTERACTIONS OF ORAL HYPOGLYCEMIC AGENTS IN TYPE 2 DIABETIC PATIENTS AT GUWAHATHI MEDICAL COLLEGE HOSPITAL

... To determine the incidence of adverse drug reactions and drug inter- actions due to oral hypoglycemic agents in patients suffering from type 2 diabetes. Methodology: Prior to the conduction of study, ...

8

A STUDY ON DRUG UTILIZATION PATTERN OF ORAL HYPOGLYCEMIC AGENTS IN TYPE-2 DIABETIC PATIENTS OF A TERTIARY CARE TEACHING HOSPITAL

A STUDY ON DRUG UTILIZATION PATTERN OF ORAL HYPOGLYCEMIC AGENTS IN TYPE-2 DIABETIC PATIENTS OF A TERTIARY CARE TEACHING HOSPITAL

... of oral hypoglycemic agents for diabetes mellitus type 2 patients attending out patient department at the university hospital in Newdelhi conducted by Mohammed Shamsheer Alam, Mohammed Aqil ...taking ...

8

Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City

Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City

... Introduction: Worldwide, diabetes mellitus presents a high burden for individuals and society. In Latin America, many people with diabetes have limited access to health care, which means that indirect costs may exceed ...

9

Utilization Pattern of Oral Hypoglycemic Agents for Diabetes Mellitus Type 2 Patients Attending Out Patient Department at a University Hospital in New Delhi

Utilization Pattern of Oral Hypoglycemic Agents for Diabetes Mellitus Type 2 Patients Attending Out Patient Department at a University Hospital in New Delhi

... of oral hypoglycemic agents to type 2 diabetic patients attending a university hos- pital, and to assess patient ...432 oral hypoglycemic agents were prescribed to the ...

10

PHARMACOECONOMICAL EVALUATION OF ORAL HYPOGLYCEMIC AGENTS FOR TYPE 2 DIABETES MELLITUS IN A MULTISPECIALITY HOSPITAL

PHARMACOECONOMICAL EVALUATION OF ORAL HYPOGLYCEMIC AGENTS FOR TYPE 2 DIABETES MELLITUS IN A MULTISPECIALITY HOSPITAL

... The study was included with patients of age between 20 – 80 years in both genders, having Type 2 Diabetes Mellitus prescribed with oral hypoglycemic agents. We excluded patients with age < 20 and ...

6

Impact of oral hypoglycemic agents on mortality among diabetic patients with non muscle invasive bladder cancer: A population based analysis

Impact of oral hypoglycemic agents on mortality among diabetic patients with non muscle invasive bladder cancer: A population based analysis

... Ultimately, the net impact of glyburide on tumor cells remains poorly understood.(15) The current literature evaluating the impact of glyburide (and sulfonylureas in general) on cancer incidence and cancer-related ...

21

Patterns of Adherence to Oral Hypoglycemic Agents: Patterns, Correlates, and Outcomes

Patterns of Adherence to Oral Hypoglycemic Agents: Patterns, Correlates, and Outcomes

... microvascular complications and adverse events, diabetes control remains sub-optimal. Poor adherence to recommended regimens is a causal factor in preventable morbidity and mortality in diabetic patients. Sub- groups of ...

78

Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents

Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents

... of oral anti-diabetic agents that increase circulating concentrations of the glucagon-like peptide-1 (GLP-1) ...traditional oral hypoglycemic agents in terms of the efficacy and ...

9

Oral hypoglycemic agents: do the ends justify the means?

Oral hypoglycemic agents: do the ends justify the means?

... Historically, insulin has been the recommended treat- ment for GDM in the U.S. when dietary and lifestyle measures have failed. Today, randomized controlled tri- als support the efficacy and short-term safety of glybur- ...

10

Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes

Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes

... Cox regression analysis was performed to investigate the pre- dictive factors for resumption of insulin therapy for glucose control in subjects who switched to OHAs from initial insulin therapy (Group IA vs. Group IB) ...

9

Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice

Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice

... Results: After 20 weeks treatment with exenatide, mean HbA1c and body weight were significantly reduced from 8.4% to 7.7% and from 83.4 kg to 80.2 kg, respectively (both p < 0.001). Subjects with higher baseline ...

9

Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population

Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population

... on drug safety and efficacy, drug- utilization patterns and clinical effective- ness in a “real-world” setting may differ substantially from the data provided from such trials. In particular, agent tolerabil- ity, ...

5

COMPARE THE EFFICACY AND SAFETY OF DIPEPTIDYL PEPTIDASE 4 INHIBITORS WITH OTHER ORAL HYPOGLYCEMIC AGENTS IN TYPE 2 DIABETES MELLITUS PATIENTS

COMPARE THE EFFICACY AND SAFETY OF DIPEPTIDYL PEPTIDASE 4 INHIBITORS WITH OTHER ORAL HYPOGLYCEMIC AGENTS IN TYPE 2 DIABETES MELLITUS PATIENTS

... The National Institute of Health and Clinical Excellence (NICE) suggests adding DPP-4 inhibitors instead of sulfonyl urea as second line treatment to metformin, if there is considerable risk of hypoglycemia or if ...

5

Vitamin B12 deficiency among vegetarian and non-vegetarian diabetic population receiving prolonged Metformin based oral hypoglycemic agents therapy

Vitamin B12 deficiency among vegetarian and non-vegetarian diabetic population receiving prolonged Metformin based oral hypoglycemic agents therapy

... Background: Diabetes is a group of metabolic disorder that share the phenotype of hyperglycemia. Over the period of time the metabolic dysregulation associated with diabetes mellitus causes secondary pathophysiological ...

5

Study of Prescription Pattern of Oral Hypoglycemic Agents in Relation to Gfr Appropriateness in Diabetes Mellitus with Nephropathy

Study of Prescription Pattern of Oral Hypoglycemic Agents in Relation to Gfr Appropriateness in Diabetes Mellitus with Nephropathy

... concluded that in case of metformin and sulphonylureas the daily dose should be reduced according to glomerular filtration rate (GFR) or even the drug is contraindicated in presence of severe CKD. New anti-diabetic ...

7

DIAGNOSIS AND TREATMENT: SHOULD ORAL HYPOGLYCEMIC AGENTS BE USED IN PEDIATRIC AND PREGNANT PATIENTS?

DIAGNOSIS AND TREATMENT: SHOULD ORAL HYPOGLYCEMIC AGENTS BE USED IN PEDIATRIC AND PREGNANT PATIENTS?

... blood sugar and abnormal glucose tolerance or cortisone-glucose tolerance tests and dia- betic children in the non-insulin dependent.. phase of a biphasic course might be con-.[r] ...

7

Show all 10000 documents...

Related subjects